Outset Medical, Inc. provided revenue guidance for the full year 2023. for the year, the company expects revenue guidance range of $144 million to $150 million, and now expects to be at the low end of this range as a result of the shipment pause for TabloCart with Prefiltration.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.61 USD | 0.00% | +16.45% | -33.27% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.27% | 187M | |
+11.91% | 227B | |
+15.46% | 198B | |
+18.58% | 142B | |
+30.36% | 111B | |
+0.23% | 64.16B | |
+17.74% | 54.1B | |
+5.82% | 51.41B | |
+11.23% | 45.32B | |
+5.73% | 37.32B |
- Stock Market
- Equities
- OM Stock
- News Outset Medical, Inc.
- Outset Medical, Inc. Provides Revenue Guidance for the Full Year 2023